Company Profile

ImmunArtes LLC
Profile last edited on: 2/25/2022      CAGE: 82S33      UEI: ETMGB9KR3GG4

Business Identifier: Vaccine products against Staphylococcus aureus
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

?1463 East 53rd Street Floor 2
Chicago, IL 60615
   (630) 568-5066
Location: Single
Congr. District: 01
County: Cook

Public Profile

A startup tackling work developed by a group of scientists from the University of Chicago, ImmunArtes LLC is addressing development of vaccine products against Staphylococcus aureus, a bacterium that colonizes one-third of the world's population. By taking the form of MRSA -- a dangerous superbug resistant to antibiotic treatment -- Staph poses a world-health crisis estimated currently be taking some 19,000 lives per year. No successful vaccine against it has so far been developed. ImmunArtes' founders have discovered that a mechanism called Protein A allows the bacterium to evade the human immune system. Thus, the vaccine created by ImmunArtes is designed specifically targets Protein A, the first technology of its kind.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $253,925
Project Title: Optimal adjuvant/antigen formulation toward a Staphylococcus aureus human vaccine
2021 1 NIH $257,842
Project Title: Development of a Vaccine for Staphylococcal Infections

Key People / Management

  Hwan Keun Kim -- Chief Operating Officer

  Dominique M Missiakas -- Chief Scientific Officer

  Olaf Schneewind -- Chief Medical Officer

Company News

There are no news available.